qRT-PCR and Western blotting verified that UGP2 mRNA and protein expression levels in CRC tissue samples were significantly lower than those in normal tissues (p < 0.0001, p < 0.01; Figure 1J,K). This evidence concerns the gene UGP2 and colorectal carcinoma.